{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:14:15Z","timestamp":1791472455060,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jaip.2024.01.021","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T17:10:45Z","timestamp":1706116245000},"page":"1192-1201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Severe Multiple Drug Intolerance Syndrome in Fibromyalgia and Irritable Bowel Syndrome"],"prefix":"10.1016","volume":"12","author":[{"given":"Alicia A.","family":"Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayme M.","family":"Palka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.01.021_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.anai.2011.11.006","article-title":"Multiple drug intolerance syndrome: prevalence, clinical characteristics, and management","volume":"108","author":"Macy","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.01.021_bib2","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/all.13440","article-title":"Multiple drug intolerance syndrome and multiple drug allergy syndrome: epidemiology and associations with anxiety and depression","volume":"73","author":"Blumenthal","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.01.021_bib3","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s40264-014-0236-x","article-title":"Multiple drug intolerance syndrome: a large-scale retrospective study","volume":"37","author":"Omer","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2024.01.021_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.psym.2018.07.016","article-title":"Polyallergy (multiple chemical sensitivity) is associated with excessive healthcare utilization, greater psychotropic use, and greater mental health\/functional somatic syndrome disorder diagnoses: a large cohort retrospective study","volume":"60","author":"Jimenez","year":"2019","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jaip.2024.01.021_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11739-011-0510-1","article-title":"Allergy and psychologic evaluations of patients with multiple drug intolerance syndrome","volume":"7","author":"de Pasquale","year":"2012","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jaip.2024.01.021_bib6","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/ajg.2010.40","article-title":"Impact of functional gastrointestinal disorders on survival in the community","volume":"105","author":"Chang","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2024.01.021_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12876-020-01593-5","article-title":"The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis","volume":"21","author":"Hu","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jaip.2024.01.021_bib8","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2024.01.021_bib9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment","volume":"16","author":"Sarzi-Puttini","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaip.2024.01.021_bib10","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1185\/03007990802316550","article-title":"Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany","volume":"24","author":"Berger","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaip.2024.01.021_bib11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.7205\/MILMED-D-13-00419","article-title":"Prevalence, health care utilization, and costs of fibromyalgia, irritable bowel, and chronic fatigue syndromes in the military health system, 2006-2010","volume":"179","author":"Jeffery","year":"2014","journal-title":"Mil Med"},{"key":"10.1016\/j.jaip.2024.01.021_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ajg.2017.421","article-title":"The prevalence and impact of overlapping Rome IV-diagnosed functional gastrointestinal disorders on somatization, quality of life, and healthcare utilization: a cross-sectional general population study in three countries","volume":"113","author":"Aziz","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2024.01.021_bib13","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/apt.12938","article-title":"Review article: the economic impact of the irritable bowel syndrome","volume":"40","author":"Canavan","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaip.2024.01.021_bib14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/art.21545","article-title":"The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice","volume":"54","author":"Hughes","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2024.01.021_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.semarthrit.2006.12.009","article-title":"Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes","volume":"36","author":"Yunus","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaip.2024.01.021_bib16","article-title":"Fibromyalgia and associated disorders: from pain to chronic suffering, from subjective hypersensitivity to hypersensitivity syndrome","volume":"8","author":"Maugars","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2024.01.021_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jaip.2024.01.021_bib18","doi-asserted-by":"crossref","first-page":"E62","DOI":"10.3399\/bjgp21X714245","article-title":"Influence of polypharmacy on patients with heart failure with preserved ejection fraction: a retrospective analysis on adverse outcomes in the TOPCAT trial","volume":"71","author":"Wu","year":"2021","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.jaip.2024.01.021_bib19","first-page":"51","article-title":"Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy","volume":"27","author":"Whitney","year":"2021","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.jaip.2024.01.021_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chron Dis"},{"key":"10.1016\/j.jaip.2024.01.021_bib21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaip.2019.06.009","article-title":"Multiple drug hypersensitivity syndrome in a large database","volume":"8","author":"Landry","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.01.021_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-014-0476-y","article-title":"Penicillin and beta-lactam allergy: epidemiology and diagnosis","volume":"14","author":"Macy","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2024.01.021_bib23","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/all.12881","article-title":"Drug allergies documented in electronic health records of a large healthcare system","volume":"71","author":"Zhou","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.01.021_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.14309\/ajg.0000000000000573","article-title":"Mortality risk in irritable bowel syndrome: results from a nationwide prospective cohort study","volume":"115","author":"Staller","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2024.01.021_bib25","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.mayocp.2016.04.029","article-title":"Chronic pain and mental health disorders: shared neural mechanisms, epidemiology, and treatment","volume":"91","author":"Hooten","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaip.2024.01.021_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138024","article-title":"The prevalence and characteristics of fibromyalgia in the 2012 national health interview survey","volume":"10","author":"Walitt","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2024.01.021_bib27","doi-asserted-by":"crossref","first-page":"127.e1","DOI":"10.1016\/j.ejpain.2009.03.010","article-title":"Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain","volume":"14","author":"Gormsen","year":"2010","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jaip.2024.01.021_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pain.2006.04.004","article-title":"Psychiatric comorbidities in a community sample of women with fibromyalgia","volume":"124","author":"Raphael","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.jaip.2024.01.021_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-230X-6-26","article-title":"Migraine, fibromyalgia, and depression among people with IBS: a prevalence study","volume":"6","author":"Cole","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jaip.2024.01.021_bib30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jpsychires.2020.08.014","article-title":"Trends in anxiety among adults in the United States, 2008-2018: rapid increases among young adults","volume":"130","author":"Goodwin","year":"2020","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.jaip.2024.01.021_bib31","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2024.01.021_bib32","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/acr.21896","article-title":"Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester epidemiology project","volume":"65","author":"Vincent","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"Suppl 69","key":"10.1016\/j.jaip.2024.01.021_bib33","first-page":"S79","article-title":"Fibromyalgia: prevalence, course, and co-morbidities in hospitalized patients in the United States, 1999-2007","volume":"29","author":"Haviland","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaip.2024.01.021_bib34","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.38905","article-title":"The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria","volume":"67","author":"Jones","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaip.2024.01.021_bib35","doi-asserted-by":"crossref","first-page":"544","DOI":"10.5056\/jnm18082","article-title":"Sex-gender differences in irritable bowel syndrome","volume":"24","author":"Kim","year":"2018","journal-title":"J\u00a0Neurogastroenterol Motil"},{"key":"10.1016\/j.jaip.2024.01.021_bib36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.14309\/ajg.0000000000000502","article-title":"Presentation and characteristics of abdominal pain vary by irritable bowel syndrome subtype: results of a nationwide population-based study","volume":"115","author":"Shah","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2024.01.021_bib37","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/01.mcg.0000140190.65405.fb","article-title":"Racial differences in the impact of irritable bowel syndrome on health-related quality of life","volume":"38","author":"Gralnek","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jaip.2024.01.021_bib38","doi-asserted-by":"crossref","first-page":"737","DOI":"10.12788\/jhm.3256","article-title":"Opioid utilization and perception of pain control in hospitalized patients: a cross-sectional study of 11 sites in 8 countries","volume":"14","author":"Burden","year":"2019","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.jaip.2024.01.021_bib39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.amjsurg.2021.03.044","article-title":"Public perception on opioids & pain management after major surgery","volume":"223","author":"Juprasert","year":"2022","journal-title":"Am J Surg"},{"key":"10.1016\/j.jaip.2024.01.021_bib40","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jaip.2017.03.035","article-title":"Opioid hypersensitivity: predictors of allergy and role of drug provocation testing","volume":"5","author":"Li","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.01.021_bib41","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jamia\/ocv143","article-title":"Rising drug allergy alert overrides in electronic health records: an observational retrospective study of a decade of experience","volume":"23","author":"Topaz","year":"2016","journal-title":"J\u00a0Am Med Inform Assoc"},{"key":"10.1016\/j.jaip.2024.01.021_bib42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12916-018-1022-x","article-title":"Antidepressant use and risk of adverse outcomes in people aged 20-64 years: cohort study using a primary care database","volume":"16","author":"Coupland","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.jaip.2024.01.021_bib43","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jaip.2018.11.023","article-title":"Drug hypersensitivity reactions documented in electronic health records within a large health system","volume":"7","author":"Wong","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.01.021_bib44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.psychres.2017.07.003","article-title":"The interpersonal adverse effects reported by 1008 users of antidepressants; and the incremental impact of polypharmacy","volume":"256","author":"Read","year":"2017","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jaip.2024.01.021_bib45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/phar.1398","article-title":"Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options","volume":"34","author":"Drozda","year":"2014","journal-title":"Pharmacotherapy"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824000734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824000734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T06:00:43Z","timestamp":1724479243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824000734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2213219824000734"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.01.021","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe Multiple Drug Intolerance Syndrome in Fibromyalgia and Irritable Bowel Syndrome","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}